Literature DB >> 2128131

Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls.

I Dale1.   

Abstract

Release of the calcium-binding protein L1 from blood granulocytes in vitro was found to be strongly influenced by anticoagulants and was accelerated during blood clotting. EDTA effectively inhibited this release. The material of choice for obtaining base-line L1 levels in blood is, therefore, EDTA plasma. Care should be taken to avoid admixture with cells from the buffy coat. The reference interval for L1 concentrations in plasma was established by testing samples from 533 blood donors. The L1 distribution proved in both sexes to be log-normal. The reference interval in females was 90 to 530 micrograms/l, and in males 120 to 660 micrograms/l. A positive correlation was found between the L1 level and the white blood cell count (r = 0.46, p = 0.0001).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128131     DOI: 10.3109/00365519009104950

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  Calprotectin as a marker of inflammation in cystic fibrosis.

Authors:  B E Golden; P A Clohessy; G Russell; M K Fagerhol
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 2.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

Review 3.  Calprotectin: Clinical Applications in Pediatrics.

Authors:  Oscar R Herrera; Michael L Christensen; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jul-Aug

4.  Circulating Calprotectin as a Biomarker of COVID-19 Severity.

Authors:  Michael Mahler; Pier-Luigi Meroni; Maria Infantino; Katherine A Buhler; Marvin J Fritzler
Journal:  Expert Rev Clin Immunol       Date:  2021-04-13       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.